1e
19
1
49
2
2
18
1b
1d
18
3b
74
1d
2 29
1d
25
Andrew M Courtwright, MD, PhD
78
74
Associate Professor of Clinical Medicine (Pulmonary, Allergy and Critical Care)
28
a9
3
5f
Advanced Lung Disease and Lung Transplantation Fellowship Program Director, Hospital of University of Pennsylvania
11
Department: Medicine
4
1
b
1d
46
Contact information
40
4
3
3
3
2
4
b
1f
40
3400 Spruce Street
2c Gates 940
Philadelphia, PA 19104
26
2c Gates 940
Philadelphia, PA 19104
2e
Office: 215-615-4142
32 Fax: 215-349-8235
24
f
32 Fax: 215-349-8235
24
13
Education:
21 7 BA 17 (Philosophy) c
28 Rice University, 2001.
21 7 BA 14 (Biology) c
28 Rice University, 2001.
21 7 MA 17 (Philosophy) c
35 University of North Carolina, 2006.
21 8 PhD 17 (Philosophy) c
35 University of North Carolina, 2007.
21 7 MD 15 (Medicine) c
35 University of North Carolina, 2009.
c
3
3
3
3
8d
Permanent link21 7 BA 17 (Philosophy) c
28 Rice University, 2001.
21 7 BA 14 (Biology) c
28 Rice University, 2001.
21 7 MA 17 (Philosophy) c
35 University of North Carolina, 2006.
21 8 PhD 17 (Philosophy) c
35 University of North Carolina, 2007.
21 7 MD 15 (Medicine) c
35 University of North Carolina, 2009.
c
2 29
21
1e
1d
24
5e
1c Lung transplantation
1f Short telomere syndrome
21 Telomere biology disorders
71
8
2f6 Dr. Courtwright is currently focused on three projects: 1) refining our understanding of HLA antibodies pre- and post-transplant to improve access to lung transplantation for sensitized patients. 2) Strategies for expanding the lung donor pool, including utilization of hepatitis B donors. 3) Transplantation ethics, including organ procurement via normothermic regional perfusion and xenotransplantation. In addition, he is involved in collaborative work on telomere biology disorders and lung transplantation with Brigham and Women’s Hospital, ethics consultation research with the Massachusetts General Hospital Ethics Committee, and bacteriophage therapy and infection following lung transplantation with the University of California San Diego.
e 29
27
Description of Clinical Expertise
2a Interstitial lung disease1c Lung transplantation
1f Short telomere syndrome
21 Telomere biology disorders
71
Description of Research Expertise
d6 Dr. Courtwright is a clinician in the Department of Pulmonary and Critical Care Medicine. His research is divided between issues in resource allocation in lung transplantation and clinical ethics.8
2f6 Dr. Courtwright is currently focused on three projects: 1) refining our understanding of HLA antibodies pre- and post-transplant to improve access to lung transplantation for sensitized patients. 2) Strategies for expanding the lung donor pool, including utilization of hepatitis B donors. 3) Transplantation ethics, including organ procurement via normothermic regional perfusion and xenotransplantation. In addition, he is involved in collaborative work on telomere biology disorders and lung transplantation with Brigham and Women’s Hospital, ethics consultation research with the Massachusetts General Hospital Ethics Committee, and bacteriophage therapy and infection following lung transplantation with the University of California San Diego.
e 29
23
165 Nathan AS, Blebea C, Chatterjee P, Thomasson A, Diamond JM, Groeneveld PW, Giri J, Goldberg HJ, Courtwright AM. : Mortality trends around the one‐year survival mark after heart, liver, and lung transplantation in the United States. Clinical Transplantation 34(2): e13852, Jun 2020.
151 Courtwright AM, Rubin E, Robinson EM, Thomasson A, El-Chemaly S, Diamond JM, Goldberg HJ. : In-hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization. American Journal of Transplantation 19(2): 532-9, Oct 2018.
117 Lamas Daniela J, Lakin Joshua R, Trindade Anil J, Courtwright Andrew, Goldberg Hilary: Looking beyond mortality in transplantation outcomes. The New England Journal of Medicine 379(20): 1889-1891, Mar 2018.
148 Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ: Clinical outcomes of lung transplantation in the presence of donor-specific antibodies. Annals of the American Thoracic Society 16(9): 1131-1137, Sep 2019.
184 Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S: Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PloS One 11(9): e0162409, Sep 2016.
142 Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg HJ: Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease. The Journal of Heart and Lung Transplantation 36(7): 763-9, Jul 2017.
128 Courtwright AM, Robinson EM, Feins K, Carr-Loveland J, Donahue V, Roy N, McCannon J: Ethics committee consultation and extracorporeal membrane oxygenation. Annals of the American Thoracic Society 13(9): 1553-1558, Nov 2016.
10e Robinson EM, Cadge W, Zollfrank AA, Cremens MC, Courtwright AM: After the DNR: Surrogates who persist in requesting cardiopulmonary resuscitation. The Hastings Center Report 47(1): 10-19, Feb 2017.
a5 Courtwright, AM: Stigmatization and public health ethics. Bioethics 27(2): 74-80, Aug 2011.
2c
7
1d
1f
Selected Publications
159 Drolen C, Cantu E, Goldberg HJ, Diamond JM, Courtwright AM: Impact of the elimination of the Donation Service Area on United States lung transplant practices and outcomes at high and low competition centers. American Journal of Transplantation 20(12): 3271-3703, Dec 2020.165 Nathan AS, Blebea C, Chatterjee P, Thomasson A, Diamond JM, Groeneveld PW, Giri J, Goldberg HJ, Courtwright AM. : Mortality trends around the one‐year survival mark after heart, liver, and lung transplantation in the United States. Clinical Transplantation 34(2): e13852, Jun 2020.
151 Courtwright AM, Rubin E, Robinson EM, Thomasson A, El-Chemaly S, Diamond JM, Goldberg HJ. : In-hospital and subsequent mortality among lung transplant recipients with a prolonged initial hospitalization. American Journal of Transplantation 19(2): 532-9, Oct 2018.
117 Lamas Daniela J, Lakin Joshua R, Trindade Anil J, Courtwright Andrew, Goldberg Hilary: Looking beyond mortality in transplantation outcomes. The New England Journal of Medicine 379(20): 1889-1891, Mar 2018.
148 Courtwright AM, Cao S, Wood I, Mallidi HR, Kawasawa J, Moniodis A, Ng J, El-Chemaly S, Goldberg HJ: Clinical outcomes of lung transplantation in the presence of donor-specific antibodies. Annals of the American Thoracic Society 16(9): 1131-1137, Sep 2019.
184 Courtwright AM, Fried S, Villalba JA, Moniodis A, Guleria I, Wood I, Milford E, Mallidi HH, Hunninghake GM, Raby BA, Agarwal S, Camp PC, Rosas IO, Goldberg HJ, El-Chemaly S: Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PloS One 11(9): e0162409, Sep 2016.
142 Courtwright AM, El-Chemaly S, Dellaripa PF, Goldberg HJ: Survival and outcomes after lung transplantation for non-scleroderma connective tissue-related interstitial lung disease. The Journal of Heart and Lung Transplantation 36(7): 763-9, Jul 2017.
128 Courtwright AM, Robinson EM, Feins K, Carr-Loveland J, Donahue V, Roy N, McCannon J: Ethics committee consultation and extracorporeal membrane oxygenation. Annals of the American Thoracic Society 13(9): 1553-1558, Nov 2016.
10e Robinson EM, Cadge W, Zollfrank AA, Cremens MC, Courtwright AM: After the DNR: Surrogates who persist in requesting cardiopulmonary resuscitation. The Hastings Center Report 47(1): 10-19, Feb 2017.
a5 Courtwright, AM: Stigmatization and public health ethics. Bioethics 27(2): 74-80, Aug 2011.
2c